FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102102 [Registered on: 27/01/2026] Trial Registered Prospectively
Last Modified On: 27/01/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Other 
Public Title of Study   Multani Mitti vs. Niacinamide Serum: A Comparative Study on Facial Sebum (Oil) Control 
Scientific Title of Study   Efficacy of a Multani Mitti (Fullers Earth) Face Pack versus 10 percent Niacinamide Serum on Facial Sebum Secretion: A Low-Cost Comparative Split-Face Pilot Study 
Trial Acronym  NOT APPLICABLE 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Khan Shama Yasmeen Zaheer Ahmad 
Designation  Student 
Affiliation  Z.V.M. Unani Medical College and Hospital, Pune 
Address  Z.V.M. Unani Medical College and Hospital, Gate No. 4, Azam Campus, K B Hidayatullah Road, 2390, Shankar Sheth Rd, Pune, Maharashtra 411001

Pune
MAHARASHTRA
411001
India 
Phone  9307090441  
Fax    
Email  khanshamazaheer@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sayed Tauleha Tabassum Tayyeb Bukhari 
Designation  Assistant Professor 
Affiliation  Z.V.M. Unani Medical College and Hospital, Pune 
Address  Z.V.M. Unani Medical College and Hospital, Gate No. 4, Azam Campus, K B Hidayatullah Road, 2390, Shankar Sheth Rd, Pune, Maharashtra 411001

Pune
MAHARASHTRA
411001
India 
Phone  7666349418  
Fax    
Email  taulehabukhari20@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sayed Tauleha Tabassum Tayyeb Bukhari 
Designation  Assistant Professor 
Affiliation  Z.V.M. Unani Medical College and Hospital, Pune 
Address  Z.V.M. Unani Medical College and Hospital, Gate No. 4, Azam Campus, K B Hidayatullah Road, 2390, Shankar Sheth Rd, Pune, Maharashtra 411001

Pune
MAHARASHTRA
411001
India 
Phone  7666349418  
Fax    
Email  taulehabukhari20@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research in Unani Medicine (CCRUM), Ministry of Ayush, Government of India, 61-65, Institutional Area, Opposite D-Block, Janakpuri, New Delhi-110058, India. 
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine (CCRUM), Ministry of Ayush, Government of India 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Avum Homeopathy Anusandhan Bhavan No.61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi - 110058 (India) 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sayed Tauleha Tabassum Tayyeb Bukhari  Z.V.M. Unani Medical College and Hospital, Pue  Gate No. 4, Azam Campus, K B Hidayatullah Road, 2390, Shankar Sheth Rd, Pune, Maharashtra 411001
Pune
MAHARASHTRA 
7666349418

taulehabukhari20@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee of M.C.E. Society  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  The trial involves healthy individuals aged 18–35 with confirmed oily skin 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  10 percent Niacinamide Serum  Comparator Product (C): A commercially available, water-based 10 percent Niacinamide serum (fragrance and oil-free) 10 percent Niacinamide Serum: Applied once daily on the assigned side of the face. 
Intervention  Multani Mitti (Fullers Earth) Face Pack   Test Product (T): Multani Mitti Face Pack. Standardized preparation: 20 grams of pure, cosmetic-grade Multani Mitti powder will be mixed with a sufficient quantity of Arq-i-Gulab (Rose Water) to form a consistent, smooth paste immediately before application. Frequency of Intervention: Multani Mitti Face Pack: Applied twice weekly on the assigned side of the face, each application kept for 15 minutes, followed by rinsing with water. Total Duration of Intervention: The intervention for both study arms will be continued for a total duration of 4 weeks (28 days). 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  1. Healthy male and female individuals between the age of 18 to 35 years.
2. Oily skin type confirmed at baseline using the blotting paper method, defined as a translucent oil spot of Grade 3 or More than Grade 3 on a 0-5 visual grading scale.
3. Individuals must show their willingness to provide written informed consent and comply with the study protocol which include a 1-week washout for every other facial topical treatment
 
 
ExclusionCriteria 
Details  1. Known allergy to cosmetic products, clay or Niacinamide.
2. Active facial dermatoses (e.g., cystic acne, rosacea, atopic dermatitis).
3. Use of systemic or topical medications known to influence sebum production (e.g., oral/topical retinoids, hormonal agents) in the past 3 months.
4. Pregnancy or lactation. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Primary (Sebum Secretion): Standardized blotting paper technique. A standard blotting paper (e.g., 5 cm x 5 cm) will be pressed firmly onto the forehead on each side for 10 seconds. The resulting translucent oil spot will be immediately graded by the blinded assessor against a validated 5-point visual scale (0=No spot, 1=Faint spot, 2=Moderate spot, 3=Large, distinct spot, 4=Saturated spot, 5=Oversaturated spot). The change in grade from Day 0 to Day 28 will be the primary outcome.  Time points for outcome assessment in the present study are as follows:

Baseline (Day 0):
Assessment of facial sebum secretion using the blotting paper method and self-perceived oiliness using Visual Analogue Scale (VAS), prior to initiation of intervention.

End of Intervention – 4 Weeks (Day 28):
Re-assessment of facial sebum secretion and VAS scores to evaluate the effect of the interventions. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="28" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This single-blind, randomized split-face pilot study compares the efficacy of a traditional Multani Mitti face pack against a 10 percent Niacinamide serum in reducing facial sebum secretion over a four-week period. Ten participants with clinically confirmed oily skin apply Multani Mitti twice weekly to one assigned side of the face and Niacinamide serum once daily to the other. Success is measured primarily by a standardized blotting paper visual grading scale (0-5) to assess changes in oil spots, alongside secondary measures for local safety and self-perceived oiliness. 
Close